Literature DB >> 12601524

Polymorphisms of the tumor necrosis factor receptors: no association with narcolepsy in German patients.

Stefan Wieczorek1, Norbert Dahmen, Peter Jagiello, Joerg T Epplen, Martin Gencik.   

Abstract

Narcolepsy is a debilitating sleep disorder characterized by daytime sleepiness and cataplexy. The strong association of narcolepsy with the HLA system suggests an autoimmune cause. Tumor necrosis factor is a cytokine involved in both regulation of immune mechanisms and sleep. Several studies were undertaken to determine a contribution of tumor necrosis factor and its receptors to the pathogenesis of narcolepsy. A significant increase in the 196R allele, a functionally relevant polymorphism in the TNFR2 gene, has been found in Japanese patients, indicating altered transduction of tumor necrosis factor signals. Here we explore polymorphisms in both tumor necrosis factor receptor genes as risk factors in a German population sample. Neither the polymorphism in the TNFR1 nor that in the TNFR2 gene was associated with narcolepsy. Our findings contrast to those previously published and thus provide evidence for genetic heterogeneity between different narcolepsy populations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601524     DOI: 10.1007/s00109-002-0405-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  16 in total

Review 1.  Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions.

Authors:  J M Mullington; D Hinze-Selch; T Pollmächer
Journal:  Ann N Y Acad Sci       Date:  2001-03       Impact factor: 5.691

Review 2.  Narcolepsy and the HLA region.

Authors:  L Lin; M Hungs; E Mignot
Journal:  J Neuroimmunol       Date:  2001-07-02       Impact factor: 3.478

3.  The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.

Authors:  L Lin; J Faraco; R Li; H Kadotani; W Rogers; X Lin; X Qiu; P J de Jong; S Nishino; E Mignot
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

4.  A search for a mutation in the tumour necrosis factor-alpha gene in narcolepsy.

Authors:  T Kato; M Honda; S Kuwata; T Juji; M Fukuda; Y Honda; N Kato
Journal:  Psychiatry Clin Neurosci       Date:  1999-06       Impact factor: 5.188

5.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

6.  Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity.

Authors:  A N Vgontzas; D A Papanicolaou; E O Bixler; A Kales; K Tyson; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1997-05       Impact factor: 5.958

Review 7.  Narcolepsy.

Authors:  M S Aldrich
Journal:  Neurology       Date:  1992-07       Impact factor: 9.910

8.  Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

Authors:  R M Chemelli; J T Willie; C M Sinton; J K Elmquist; T Scammell; C Lee; J A Richardson; S C Williams; Y Xiong; Y Kisanuki; T E Fitch; M Nakazato; R E Hammer; C B Saper; M Yanagisawa
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

9.  Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis.

Authors:  C Morita; T Horiuchi; H Tsukamoto; N Hatta; Y Kikuchi; Y Arinobu; T Otsuka; T Sawabe; S Harashima; K Nagasawa; Y Niho
Journal:  Arthritis Rheum       Date:  2001-12

10.  DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans.

Authors:  E Mignot; X Lin; J Arrigoni; C Macaubas; F Olive; J Hallmayer; P Underhill; C Guilleminault; W C Dement; F C Grumet
Journal:  Sleep       Date:  1994-12       Impact factor: 5.849

View more
  5 in total

1.  What we learned from narcolepsy of others.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2003-02       Impact factor: 4.599

2.  Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.

Authors:  Justin P Rubio; Melanie Bahlo; Jim Stankovich; Rachel K Burfoot; Laura J Johnson; Stewart Huxtable; Helmut Butzkueven; Ling Lin; Bruce V Taylor; Terence P Speed; Trevor J Kilpatrick; Emmanuel Mignot; Simon J Foote
Journal:  Immunogenetics       Date:  2007-01-26       Impact factor: 2.846

3.  Genomewide association analysis of human narcolepsy and a new resistance gene.

Authors:  Minae Kawashima; Gen Tamiya; Akira Oka; Hirohiko Hohjoh; Takeo Juji; Takashi Ebisawa; Yutaka Honda; Hidetoshi Inoko; Katsushi Tokunaga
Journal:  Am J Hum Genet       Date:  2006-06-13       Impact factor: 11.025

4.  Night work and inflammatory markers.

Authors:  Sadeghniiat Khosro; Safaiyan Alireza; Aminian Omid; Sharifi Forough
Journal:  Indian J Occup Environ Med       Date:  2011-01

5.  Current limitations of SNP data from the public domain for studies of complex disorders: a test for ten candidate genes for obesity and osteoporosis.

Authors:  Volodymyr Dvornyk; Ji-Rong Long; Dong-Hai Xiong; Peng-Yuan Liu; Lan-Juan Zhao; Hui Shen; Yuan-Yuan Zhang; Yong-Jun Liu; Sonia Rocha-Sanchez; Peng Xiao; Robert R Recker; Hong-Wen Deng
Journal:  BMC Genet       Date:  2004-02-25       Impact factor: 2.797

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.